These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38068514)

  • 21. Echocardiographic phenotype for refined risk stratification and treatment selection in light chain amyloidosis with heart failure.
    Yang H; Li R; Ma F; Liu Y; He X; Yang Q; Wang DW; Zeng H; Wang H
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8415-8427. PubMed ID: 37084113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical impact of nonsustained ventricular tachycardia recorded by the implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy.
    Francia P; Santini D; Musumeci B; Semprini L; Adduci C; Pagannone E; Proietti G; Volpe M; Autore C
    J Cardiovasc Electrophysiol; 2014 Nov; 25(11):1180-7. PubMed ID: 25066044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Value of Circulating sST2 for the Prediction of Mortality in Patients With Cardiac Light-Chain Amyloidosis.
    Zhang Y; Xiao Y; Liu Y; Fang Q; Tian Z; Li J; Zhou D; Xie Z; Dong R; Zhang S
    Front Cardiovasc Med; 2020; 7():597472. PubMed ID: 33553254
    [No Abstract]   [Full Text] [Related]  

  • 24. Nonsustained Ventricular Tachycardia Is Independently Associated With Sustained Ventricular Arrhythmias in Nonischemic Dilated Cardiomyopathy.
    Piers SR; Androulakis AF; Yim KS; van Rein N; Venlet J; Kapel GF; Siebelink HM; Lamb HJ; Cannegieter SC; Man SC; Zeppenfeld K
    Circ Arrhythm Electrophysiol; 2022 Feb; 15(2):e009979. PubMed ID: 35089806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features and predictors of atrial fibrillation in patients with light-chain or transthyretin cardiac amyloidosis.
    Papathanasiou M; Jakstaite AM; Oubari S; Siebermair J; Wakili R; Hoffmann J; Carpinteiro A; Hagenacker T; Thimm A; Rischpler C; Kessler L; Rassaf T; Luedike P
    ESC Heart Fail; 2022 Jun; 9(3):1740-1748. PubMed ID: 35178887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis.
    Kastritis E; Palladini G; Minnema MC; Wechalekar AD; Jaccard A; Lee HC; Sanchorawala V; Gibbs S; Mollee P; Venner CP; Lu J; Schönland S; Gatt ME; Suzuki K; Kim K; Cibeira MT; Beksac M; Libby E; Valent J; Hungria V; Wong SW; Rosenzweig M; Bumma N; Huart A; Dimopoulos MA; Bhutani D; Waxman AJ; Goodman SA; Zonder JA; Lam S; Song K; Hansen T; Manier S; Roeloffzen W; Jamroziak K; Kwok F; Shimazaki C; Kim JS; Crusoe E; Ahmadi T; Tran N; Qin X; Vasey SY; Tromp B; Schecter JM; Weiss BM; Zhuang SH; Vermeulen J; Merlini G; Comenzo RL;
    N Engl J Med; 2021 Jul; 385(1):46-58. PubMed ID: 34192431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incremental Value of Global Longitudinal Strain for Predicting Survival in Patients With Advanced AL Amyloidosis.
    Lee Chuy K; Drill E; Yang JC; Landau H; Hassoun H; Nahhas O; Chen CL; Yu AF; Steingart RM; Liu JE
    JACC CardioOncol; 2020 Jun; 2(2):223-231. PubMed ID: 33117993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel echocardiographic risk score for light-chain amyloidosis.
    Geenty P; Sivapathan S; Stefani LD; Zada M; Boyd A; Richards D; Kwok F; Thomas L
    Eur Heart J Open; 2023 May; 3(3):oead040. PubMed ID: 37143609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and imaging predictors of 1-year and long-term mortality in light chain (AL) amyloidosis: a 5-year follow-up study.
    Migrino RQ; Harmann L; Christenson R; Hari P
    Heart Vessels; 2014 Nov; 29(6):793-800. PubMed ID: 24141988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators.
    Doval HC; Nul DR; Grancelli HO; Varini SD; Soifer S; Corrado G; Dubner S; Scapin O; Perrone SV
    Circulation; 1996 Dec; 94(12):3198-203. PubMed ID: 8989129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left and right ventricular myocardial deformation and late gadolinium enhancement: incremental prognostic value in amyloid light-chain amyloidosis.
    Li X; Li J; Lin L; Shen K; Tian Z; Sun J; Zhang C; An J; Jin Z; Vliegenthart R; Selvanayagam JB; Wang Y
    Cardiovasc Diagn Ther; 2020 Jun; 10(3):470-480. PubMed ID: 32695626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AL amyloidosis: The effect of fluorescent in situ hybridization abnormalities on organ involvement and survival.
    Ozga M; Zhao Q; Benson D; Elder P; Williams N; Bumma N; Rosko A; Chaudhry M; Khan A; Devarakonda S; Kahwash R; Vallakati A; Campbell C; Parikh SV; Almaani S; Prosek J; Bittengle J; Pfund K; LoRusso S; Freimer M; Redder E; Efebera Y; Sharma N
    Cancer Med; 2021 Feb; 10(3):965-973. PubMed ID: 33347707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum high-density lipoprotein cholesterol serves as a prognostic marker for light-chain cardiac amyloidosis.
    Yang T; Wan K; Song R; Guo X; Xu Y; Wang J; Zhang Q; Alexander KM; Liao R; Chen Y
    Int J Cardiol; 2021 Feb; 325():96-102. PubMed ID: 33080283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malnutrition at diagnosis predicts mortality in patients with systemic immunoglobulin light-chain amyloidosis independently of cardiac stage and response to treatment.
    Caccialanza R; Palladini G; Klersy C; Cereda E; Bonardi C; Cameletti B; Quarleri L; Montagna E; Foli A; Milani P; Lavatelli F; Marena C; Merlini G
    JPEN J Parenter Enteral Nutr; 2014 Sep; 38(7):891-4. PubMed ID: 24072737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A clinical retrospective analysis of newly diagnosed multiple myeloma patients with systemic light chain amyloidosis].
    Liu Y; You HY; Yan LZ; Jin S; Shang JJ; Shi XL; Yan S; Yao WQ; Wu DP; Liu W; Fu CC
    Zhonghua Xue Ye Xue Za Zhi; 2022 Apr; 43(4):330-335. PubMed ID: 35680633
    [No Abstract]   [Full Text] [Related]  

  • 37. Outcomes of Patients with Light Chain Amyloidosis Who Had Autologous Stem Cell Transplantation with 3 or More Organs Involved.
    Al Saleh AS; Sidiqi MH; Muchtar E; Dispenzieri A; Buadi FK; Dingli D; Lacy MQ; Warsame RM; Gonsalves WI; Kourelis TV; Hogan WJ; Hayman SR; Kapoor P; Kumar SK; Gertz MA
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1520-1525. PubMed ID: 31054986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac Amyloid Load: A Prognostic and Predictive Biomarker in Patients With Light-Chain Amyloidosis.
    Kristen AV; Brokbals E; Aus dem Siepen F; Bauer R; Hein S; Aurich M; Riffel J; Behrens HM; Krüger S; Schirmacher P; Katus HA; Röcken C
    J Am Coll Cardiol; 2016 Jul; 68(1):13-24. PubMed ID: 27364045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter.
    Ahmari SA; Bunch TJ; Chandra A; Chandra V; Ujino K; Daly RC; Kushwaha SS; Edwards BS; Maalouf YF; Seward JB; McGregor CG; Chandrasekaran K
    J Heart Lung Transplant; 2006 Jan; 25(1):53-60. PubMed ID: 16399531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Left Ventricular Myocardial Deformation on Cine MR Images: Relationship to Severity of Disease and Prognosis in Light-Chain Amyloidosis.
    Wan K; Sun J; Yang D; Liu H; Wang J; Cheng W; Zhang Q; Zeng Z; Zhang T; Greiser A; Jolly MP; Han Y; Chen Y
    Radiology; 2018 Jul; 288(1):73-80. PubMed ID: 29664336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.